Benitec Biopharma Ownership | Who Owns Benitec Biopharma?

Benitec Biopharma Ownership Summary

Benitec Biopharma is owned by 56.71% institutional investors, 3.19% insiders, and 40.09% retail investors. Suvretta capital management is the largest institutional shareholder, holding 25.59% of BNTC shares. Franklin Biotechnology Discv A(acc)USD is the top mutual fund, with 5.70% of its assets in Benitec Biopharma shares.

BNTC Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Benitec Biopharma	56.71%	3.19%	40.09%
Sector	Healthcare Stocks	279.42%	10.64%	-190.05%
Industry	Biotech Stocks	64.05%	10.69%	25.27%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Suvretta capital management	9.88M	25.59%	$115.56M
Adage capital partners gp	1.97M	5.11%	$23.08M
Nantahala capital management	838.10K	2.17%	$9.81M
Blackrock funding, inc. /de	718.69K	1.86%	$8.41M
Silverarc capital management	253.23K	0.66%	$2.96M
Awm investment company	137.98K	0.36%	$1.61M
Exoduspoint capital management, lp	76.38K	0.20%	$894.00K
Simplify asset management	69.17K	0.18%	$809.32K
Myda advisors	62.12K	0.16%	$726.76K
Marshall wace, llp	43.00K	0.11%	$503.13K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Suvretta capital management	9.88M	3.48%	$115.56M
Silverarc capital management	253.23K	0.55%	$2.96M
Nantahala capital management	838.10K	0.38%	$9.81M
Awm investment company	137.98K	0.18%	$1.61M
Myda advisors	62.12K	0.13%	$726.76K
Simplify asset management	69.17K	0.04%	$809.32K
Adage capital partners gp	1.97M	0.04%	$23.08M
Anson funds management lp	11.71K	0.02%	$137.01K
Exoduspoint capital management, lp	76.38K	0.01%	$894.00K
Xtx topco	10.85K	0.01%	$126.89K

Top Buyers

Holder	Shares	% Assets	Change
Blackrock funding, inc. /de	718.69K	0.00%	534.26K
Marshall wace, llp	43.00K	0.00%	43.00K
Anson funds management lp	11.71K	0.02%	11.71K
Xtx topco	10.85K	0.01%	10.85K
Myda advisors	62.12K	0.13%	10.12K

Top Sellers

Holder	Shares	% Assets	Change
Hrt financial lp	-	-	-25.93K
Qube research	-	-	-19.00K
Sg americas securities	-	-	-8.46K
Simplify asset management	69.17K	0.04%	-7.56K
Exoduspoint capital management, lp	76.38K	0.01%	-6.82K

New Positions

Holder	Shares	% Assets	Change	Value
Marshall wace, llp	43.00K	0.00%	43.00K	$503.13K
Anson funds management lp	11.71K	0.02%	11.71K	$137.01K
Xtx topco	10.85K	0.01%	10.85K	$126.89K
Truvestments capital	1.17K	0.00%	1.17K	$13.74K
Eversource wealth advisors	148.00	0.00%	148.00	$1.73K

Sold Out

Holder	Change
Balyasny asset management	-2.82K
Sg americas securities	-8.46K
Qube research	-19.00K
Hrt financial lp	-25.93K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	36	20.00%	21,891,366	15.23%	56	0.77%	25	8.70%	6	50.00%
Dec 31, 2024	30	20.00%	18,997,897	38.52%	86	0.52%	23	91.67%	4	-50.00%
Sep 30, 2024	25	31.58%	13,715,023	115.83%	128	3.36%	12	-20.00%	8	300.00%
Jun 30, 2024	1	-	625,000	-	23	-	1	-	-	-
Sep 30, 2023	1	-93.75%	23	-100.00%	-	0.00%	-	-100.00%	1	-66.67%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Franklin Biotechnology Discv A(acc)USD	1.50M	5.70%	-
Franklin Biotechnology Discovery A	1.21M	4.59%	-12.95K
HBM Healthcare Investments AG Ord	1.19M	4.54%	-
Vanguard Total Stock Mkt Idx Inv	506.02K	1.93%	506.02K
Janus Henderson Hrzn Biotec E2 USD	424.25K	1.62%	-16.16K
Vanguard Institutional Extnd Mkt Idx Tr	332.43K	1.27%	1.70K
iShares Russell 2000 ETF	317.19K	1.21%	-5.99K
iShares Russell 2000 Growth ETF	123.00K	0.47%	-
Fidelity Extended Market Index	116.45K	0.44%	-304.00
Vanguard Russell 2000 ETF	73.68K	0.28%	73.68K

Recent Insider Transactions

Date	Name	Activity	Value
Mar 31, 2025	SUVRETTA CAPITAL MANAGEMENT, LLC	Buy	$16.00K
Mar 31, 2025	SUVRETTA CAPITAL MANAGEMENT, LLC	Buy	$120.02K
Mar 31, 2025	SUVRETTA CAPITAL MANAGEMENT, LLC	Buy	$66.85K
Mar 31, 2025	SUVRETTA CAPITAL MANAGEMENT, LLC	Buy	$8.86K
Mar 26, 2025	SUVRETTA CAPITAL MANAGEMENT, LLC	Buy	$1.38M

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	6	-
2024 Q4	10	-
2024 Q3	-	-
2024 Q2	-	-
2024 Q1	-	-

BNTC Ownership FAQ

Who Owns Benitec Biopharma?

Benitec Biopharma shareholders are primarily institutional investors at 56.71%, followed by 3.19% insiders and 40.10% retail investors. The average institutional ownership in Benitec Biopharma's industry, Biotech Stocks , is 64.05%, which Benitec Biopharma falls below.

Who owns the most shares of Benitec Biopharma?

Benitec Biopharma’s largest shareholders are Suvretta capital management (9.88M shares, 25.59%), Adage capital partners gp (1.97M shares, 5.11%), and Nantahala capital management (838.1K shares, 2.17%). Together, they hold 32.87% of Benitec Biopharma’s total shares outstanding.

Does Blackrock own Benitec Biopharma?

BlackRock is not among the top 10 institutional shareholders of Benitec Biopharma.

Who is Benitec Biopharma’s biggest shareholder by percentage of total assets invested?

Suvretta capital management is Benitec Biopharma’s biggest shareholder by percentage of total assets invested, with 3.48% of its assets in 9.88M Benitec Biopharma shares, valued at 115.56M$.

Who is the top mutual fund holder of Benitec Biopharma shares?

Franklin Biotechnology Discv A(acc)USD is the top mutual fund holder of Benitec Biopharma shares, with 5.70% of its total shares outstanding invested in 1.5M Benitec Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools